Beta Bionics, Inc. BBNX

Set alert

Price alert · BBNX

All alert types
15.90 USD -0.85 -5.07%

At close · Nov 2

15.90 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
15.89 × 2
Ask
15.90 × 2
15.87 Day range 17.30
8.80 52-week range 32.71
YTD
-47.82%
1 year
-41.59%
Open
16.90
Prev close
16.75
Mkt cap
864.44M
Vol
804.22K
Avg vol
1.28M
EPS
-1.83
P/E
0.00
Div yield
0.00%
More statistics
Low
15.87
High
17.30
Forward P/E
-9.90
Beta
0.00
Short ratio
4.12
Inst. own
112.90%
Dividend
0.00
Ex-div date
Earnings
Feb 16, 2027
50-d avg
19.16
200-d avg
14.81
1y target
24.24

MAX chart

Chart tools
Interval

Events in this range
  • Oct 28, 2025Earnings: -0.33; estimate -0.45; surprise 26.67%
  • Feb 17, 2026Earnings: -0.3; estimate -0.42; surprise 28.57%
  • Apr 21, 2026Earnings: -0.49; estimate -0.53; surprise 7.55%
  • Jul 29, 2026Earnings: -0.53; estimate -0.58103; surprise 8.78%
  • Sep 15, 2026Rating: Baird · Neutral → Neutral
  • Sep 15, 2026Rating: Truist Securities · Buy → Buy
  • Sep 15, 2026Rating: B of A Securities · Neutral → Neutral
  • Sep 23, 2026Rating: Wells Fargo · — → Overweight
  • Sep 24, 2026Rating: Truist Securities · Buy → Buy
  • Oct 12, 2026Rating: Jefferies · — → Buy
  • Oct 27, 2026Earnings: -0.52; estimate -0.52334; surprise 0.64%
Signals (136)
NameDateAgo
MACD: Sell SignalOct 30, 20263 days ago
SMA: BearishOct 28, 20265 days ago
SMA: BearishOct 28, 20265 days ago
SMA: BullishOct 26, 20261 week ago
SMA: BearishOct 23, 20261 week ago
SMA: BullishOct 22, 20261 week ago
MACD: Buy SignalOct 22, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BearishSep 29, 20261 month ago
MACD: Sell SignalSep 29, 20261 month ago
SMA: BearishSep 28, 20261 month ago
MACD: Buy SignalSep 17, 20261 month ago
SMA: BullishSep 15, 20261 month ago
SMA: BullishSep 15, 20261 month ago
SMA: BearishSep 9, 20261 month ago
SMA: BearishSep 4, 20261 month ago
SMA: BullishSep 3, 20262 months ago
MACD: Sell SignalSep 2, 20262 months ago
SMA: BearishSep 1, 20262 months ago
MACD: Buy SignalAug 11, 20262 months ago

Newest 20 of 136.

Analyst view

Consensus: none

Price target (mean) 24.24 +52.5% upside
Target (low)
16.00
Target (mean)
24.24
Target (high)
30.40
Ratings (0m) 15 11 buy · 4 hold · 0 sell
  • Strong buy2
  • Buy9
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 13
  • 2 months ago 12
  • 3 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BBNX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.51333-0.55 – -0.46-0.33-55.5%34.59M+26.9%3
Next quarter-0.44-0.52 – -0.40-0.19-131.6%30.15M-6.1%3
Current year-1.88-2.06 – -1.61-1.38-36.4%124.36M+24.0%3
Next year-2.16-2.49 – -1.83-1.88-14.9%182.64M+46.9%3

Upgrades and downgrades

The latest rating changes

BBNX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026JefferiesInitiated—Buy
Sep 24, 2026Truist SecuritiesMaintainedBuyBuy
Sep 23, 2026Wells FargoInitiated—Overweight
Sep 15, 2026B of A SecuritiesMaintainedNeutralNeutral
Sep 15, 2026Truist SecuritiesReiteratedBuyBuy
Sep 15, 2026BairdMaintainedNeutralNeutral
Sep 14, 2026Leerink PartnersMaintainedOutperformOutperform
Aug 21, 2026William BlairInitiated—Market Perform
Jul 15, 2026Goldman SachsMaintainedBuyBuy
Jul 13, 2026Truist SecuritiesMaintainedBuyBuy
May 27, 2026Goldman SachsMaintainedBuyBuy
May 18, 2026B of A SecuritiesMaintainedNeutralNeutral
Apr 22, 2026Leerink PartnersMaintainedOutperformOutperform
Apr 22, 2026StifelMaintainedBuyBuy
Apr 15, 2026Truist SecuritiesMaintainedBuyBuy
Apr 9, 2026Goldman SachsMaintainedBuyBuy
Feb 18, 2026StifelMaintainedBuyBuy
Feb 18, 2026BairdMaintainedNeutralNeutral
Feb 4, 2026StifelMaintainedBuyBuy
Feb 2, 2026Truist SecuritiesMaintainedBuyBuy
Jan 27, 2026TD CowenInitiated—Hold
Jan 9, 2026Lake StreetMaintainedBuyBuy
Jan 5, 2026B of A SecuritiesMaintainedBuyBuy
Dec 18, 2025Truist SecuritiesMaintainedBuyBuy
Oct 29, 2025Goldman SachsMaintainedBuyBuy
Oct 29, 2025StifelReiteratedBuyBuy
Oct 29, 2025Truist SecuritiesReiteratedBuyBuy
Oct 29, 2025Piper SandlerReiteratedOverweightOverweight
Oct 1, 2025Goldman SachsUpgradeNeutralBuy
Sep 22, 2025Truist SecuritiesMaintainedBuyBuy